China Literature Limited
HKEX:0772.HK
25.4 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,011.785 | 7,625.622 | 8,668.244 | 8,525.701 | 8,347.767 | 5,038.25 | 4,095.066 | 2,556.866 | 1,606.64 | 466.208 |
| Cost of Revenue
| 3,640.322 | 3,595.519 | 4,068.801 | 4,291.625 | 4,655.744 | 2,480.271 | 2,019.626 | 1,502.019 | 1,026.106 | 263.965 |
| Gross Profit
| 3,371.463 | 4,030.103 | 4,599.443 | 4,234.076 | 3,692.023 | 2,557.979 | 2,075.44 | 1,054.847 | 580.534 | 202.243 |
| Gross Profit Ratio
| 0.481 | 0.528 | 0.531 | 0.497 | 0.442 | 0.508 | 0.507 | 0.413 | 0.361 | 0.434 |
| Reseach & Development Expenses
| 96.5 | 637.352 | 913.128 | 550.302 | 481.795 | 343.734 | 293.363 | 11.019 | 8.565 | 2.22 |
| General & Administrative Expenses
| 1,161.035 | 1,238.177 | 1,323.845 | 873.766 | 1,010.282 | 726.47 | 710.266 | 83.573 | 72.099 | 26.884 |
| Selling & Marketing Expenses
| 1,719.519 | 2,002.614 | 2,700.814 | 2,498.187 | 2,073.937 | 1,293.107 | 965.121 | 734.176 | 539.617 | 127.207 |
| SG&A
| 2,880.554 | 3,240.791 | 4,024.659 | 3,371.953 | 3,084.219 | 2,019.577 | 1,675.387 | 817.749 | 611.716 | 154.091 |
| Other Expenses
| 17.551 | -201.09 | -110.652 | -104.305 | -110.107 | -44.793 | -32.584 | 3.87 | -69.928 | -0.152 |
| Operating Expenses
| 2,766.773 | 3,039.701 | 3,914.007 | 3,267.648 | 2,974.112 | 1,974.784 | 1,642.803 | 1,107.188 | 847.931 | 198.135 |
| Operating Income
| 709.309 | 1,423.758 | 1,253.631 | 966.428 | 1,193.907 | 1,114.951 | 510.776 | 33.323 | -307.76 | 3.979 |
| Operating Income Ratio
| 0.101 | 0.187 | 0.145 | 0.113 | 0.143 | 0.221 | 0.125 | 0.013 | -0.192 | 0.009 |
| Total Other Income Expenses Net
| 245.328 | -649.938 | 1,049.437 | -5,505.148 | -14.11 | -37.15 | 134.954 | 63.645 | -49.745 | 0.137 |
| Income Before Tax
| 901.397 | 773.82 | 2,303.068 | -4,538.72 | 1,179.797 | 1,077.801 | 645.73 | 38.318 | -317.142 | 4.116 |
| Income Before Tax Ratio
| 0.129 | 0.101 | 0.266 | -0.532 | 0.141 | 0.214 | 0.158 | 0.015 | -0.197 | 0.009 |
| Income Tax Expense
| 97.85 | 166.192 | 460.141 | -38.523 | 67.663 | 165.403 | 83.038 | 7.958 | 37.017 | 25.246 |
| Net Income
| 804.879 | 608.186 | 1,846.609 | -4,500.197 | 1,095.953 | 910.636 | 556.129 | 36.683 | -347.584 | -21.13 |
| Net Income Ratio
| 0.115 | 0.08 | 0.213 | -0.528 | 0.131 | 0.181 | 0.136 | 0.014 | -0.216 | -0.045 |
| EPS
| 0.8 | 0.6 | 1.83 | -4.51 | 1.1 | 1.01 | 0.74 | 0.041 | -0.38 | -0.023 |
| EPS Diluted
| 0.79 | 0.59 | 1.82 | -4.5 | 1.09 | 1 | 0.72 | -0.061 | -0.38 | -0.023 |
| EBITDA
| 1,298.326 | 1,801.502 | 1,748.432 | -2,622.811 | 1,652.77 | 1,068.574 | 814.626 | 181.668 | -109.017 | 29.142 |
| EBITDA Ratio
| 0.185 | 0.236 | 0.202 | -0.308 | 0.198 | 0.212 | 0.199 | 0.071 | -0.068 | 0.063 |